By employing quantum dots to stain nuclear Ki67 and cytoplasmic cytokeratin, this method enabled the simultaneous quantitative analysis of these markers, improving the assessment of Ki67 in breast cancer diagnosis and prognosis [108]. This evidence concerns the gene MKI67 and breast cancer.